Work

Phase 1b study with PEGylated human IL-10 (AM0010) with 5-FU and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.4_suppl.399

Authors: J. Randolph Hecht, Aung Naing, Gerald Falchook, Manish R. Patel, Jeffrey R. Infante, Raid Aljumaily, Deborah Jean Lee Wong, Karen A. Autio, Zev A. Wainberg, Milind M. Javle, Johanna C. Bendell, Shubham Pant, Peter Van Vlasselaer, Gail Linda Brown, Martin Oft, Kyriakos P. Papadopoulos

Institutions: University of California, Los Angeles, The University of Texas MD Anderson Cancer Center, HealthONE, Sarah Cannon, Tennessee Oncology, East Carolina University, Ronald Reagan UCLA Medical Center, Memorial Sloan Kettering Cancer Center, University of Oklahoma Health Sciences Center, Telik, Inc. (United States), South Texas Accelerated Research Therapeutics

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602079569

Cites:

Cited by: 4

Related to: 10